Levosimendan versus dobutamine in septic cardiomyopathy: a randomized clinical trial on cardiac function and safety
ObjectiveThis study aims to evaluate the clinical efficacy, safety, and impact on outcomes of levosimendan compared with dobutamine in patients with septic cardiomyopathy.MethodsA randomized clinical trial was conducted in patients with septic cardiomyopathy between December 2022 and March 2024. Eli...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2025-09-01
|
| シリーズ: | Frontiers in Cardiovascular Medicine |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1641604/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|